semaglutide effects on heart VisualAbstract: Improves Outcomes in Patients with Obesity-Related Failure and Type 2 Diabetes semaglutide heart benefits of GLP-1

Part of the allure of semaglutidebeyond its capability for producing significant, sustainable weight lossis its simplicity

The side effects are predominantly temporary, manageable with the right strategies, and do not outweigh the substantial benefits semaglutide offers for weight management and metabolic health

population, may limit generalizability

Semaglutide is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, not directly linked to menstrual irregularities in clinical trials

TRIUMPH-2 data will support a combined obesity-and-diabetes indication

For decades, we told patients to lose weight and hoped lifestyle changes would stick